Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

ViroPharma, Halozyme Rise After FDA Issue Cleared Up
Investors.com
Friday, September 21, 2012 - 1:11pm
tags:
Halozyme, FDA, ViroPharma, Cinryze, hereditary angiodema
Here We Go Again With AEterna Zentaris... Again
Seeking Alpha
Friday, September 21, 2012 - 1:07pm
tags:
Aeterna Zentaris, AEZS-130, perifosine, AEZS-108
EU body backs Novartis' Galvus, Eucreas for diabetes indications
Reuters
Friday, September 21, 2012 - 1:05pm
tags:
Europe, Novartis, Galvus, Eucreas, diabetes
Vivus Shares Feel The Pain: Blockbuster Diet Drug Likely Won't Be Sold In Europe
Forbes
Friday, September 21, 2012 - 1:00pm
tags:
Vivus, Europe, Qsiva, Qsymia, obesity
Generic-Drug Fee Plan at FDA Caught Up in Budget Impasse
Bloomberg
Friday, September 21, 2012 - 12:53pm
tags:
generics, FDA
Patent Licensure Positive, Removes Barrier To Potential SGYP Pharma Partnership
Yahoo/Reuters
Friday, September 21, 2012 - 12:43pm
tags:
patents, Synergy Pharmaceuticals, Ironwood, plecanatide
Astex stops developing possible cancer treatment
Yahoo/AP
Friday, September 21, 2012 - 12:03pm
tags:
Astex, lung cancer, amuvatinib
Apixaban (Eliquis) For Atrial Fibrillation Gets Positive European Recommendation
Forbes
Friday, September 21, 2012 - 11:52am
tags:
Apizaban, Eliquis, atrial fibrillation, Europe, Pfizer, Bristol-Myers Squibb
Lilly's Cialis receives EU endorsement for new use
Yahoo/AP
Friday, September 21, 2012 - 11:51am
tags:
Eli Lilly, Cialis, Europe, erectile dysfunction
MorphoSys Chief Says MOR103 Drug Data Makes Deal More Likely
Bloomberg
Friday, September 21, 2012 - 11:35am
tags:
MorphoSys, MOR103, rheumatoid arthritis
Idenix Pharma: Guilty By Association
TheStreet.com
Friday, September 21, 2012 - 11:34am
tags:
Idenix, IDX-184, IDX-19368, hepatitis C
Johnson & Johnson: Cautiously Optimistic At $68 A Share
Seeking Alpha
Friday, September 21, 2012 - 11:32am
tags:
JNJ
Multiple sclerosis drugs seen gaining traction
Marketwatch
Friday, September 21, 2012 - 11:32am
tags:
MS, multiple sclerosis, BiogenIdec, BG-12, Aubagio, Sanofi
A Play On A Pullback In Pfizer
Seeking Alpha
Friday, September 21, 2012 - 11:31am
tags:
Pfizer
Could Amarin Be an Acquisition Target?
Motley Fool
Friday, September 21, 2012 - 11:29am
tags:
Amarin, M&A, GSK
FDA: Boehringer Parkinson's med may boost heart failure risk
Fierce Pharma
Thursday, September 20, 2012 - 12:05pm
tags:
FDA, Boehringer Ingelheim, Parkinson's Disease, Mirapex
Is Big Pharma getting too much flak from doctors?
Reuters
Thursday, September 20, 2012 - 12:02pm
tags:
physicians, Big Pharma
Bayer CEO decries pressure to lower drug prices
Reuters
Thursday, September 20, 2012 - 11:55am
tags:
Bayer, Pharma CEOs, drug pricing, Marijn Dekkers
Neuralstem Reminds Investors Of Stem Cell Rewards And Risk
Seeking Alpha
Thursday, September 20, 2012 - 11:45am
tags:
stem cells, Neuralstem
Bayer seeks EU approval for birth control patch
Reuters
Thursday, September 20, 2012 - 11:19am
tags:
Bayer, Europe, contraceptive patch, JNJ, Ortho Evra

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.